13D/13G Filings - EyePoint Pharmaceuticals Inc. (EYPT)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-06
10:55 am
Purchase
2023-12-3113GEyePoint Pharmaceuticals, Inc.
EYPT
FRANKLIN RESOURCES INC
BEN
4,640,651
9.500%
510,514increase
(+12.36%)
Filing
History
2023-12-14
4:04 pm
Purchase
2023-12-0413GEyePoint Pharmaceuticals, Inc.
EYPT
Cormorant Asset Management, LP6,038,235
12.360%
6,038,235increase
(New Position)
Filing
History
2023-12-08
5:28 pm
Sale
2023-12-0413DEyePoint Pharmaceuticals, Inc.
EYPT
EW Healthcare Partners, L.P.2,337,786
5.000%
-1,312,606decrease
(-35.96%)
Filing
History
2023-09-11
11:15 am
Sale
2023-08-3113GEyePoint Pharmaceuticals, Inc.
EYPT
FRANKLIN RESOURCES INC
BEN
4,130,137
11.800%
-1,644,372decrease
(-28.48%)
Filing
History
2023-08-30
5:22 pm
Sale
2019-03-2813DEyePoint Pharmaceuticals, Inc.
EYPT
EW Healthcare Partners, L.P.3,650,392
10.400%
-540,004decrease
(-12.89%)
Filing
History
2023-05-01
4:23 pm
Purchase
2023-04-2113GEyePoint Pharmaceuticals, Inc.
EYPT
Cormorant Global Healthcare Master Fund LP3,200,000
9.330%
3,200,000increase
(New Position)
Filing
History
2023-02-14
4:45 pm
Purchase
2022-12-3113GEyePoint Pharmaceuticals, Inc.
EYPT
RA Capital Management, L.P.3,408,706
9.990%
1,801,847increase
(+112.13%)
Filing
History
2023-02-13
10:23 am
Sale
2022-12-3113GEyePoint Pharmaceuticals, Inc.
EYPT
SUVRETTA CAPITAL MANAGEMENT LLC3,411,210
9.990%
-70,899decrease
(-2.04%)
Filing
History
2023-01-31
11:44 am
Purchase
2022-12-3113GEyePoint Pharmaceuticals, Inc.
EYPT
FRANKLIN RESOURCES INC
BEN
5,774,509
16.900%
827,344increase
(+16.72%)
Filing
History
2022-02-11
4:24 pm
Purchase
2021-12-3113GEyePoint Pharmaceuticals, Inc.
EYPT
SUVRETTA CAPITAL MANAGEMENT LLC3,482,109
9.990%
1,886,945increase
(+118.29%)
Filing
History
2022-02-10
09:13 am
Purchase
2021-12-3113GEyePoint Pharmaceuticals, Inc.
EYPT
ADAGE CAPITAL PARTNERS GP L.L.C.1,950,000
5.750%
450,000increase
(+30.00%)
Filing
History
2022-02-03
2:12 pm
Purchase
2021-12-3113GFIGS, Inc.
FIGS
FRANKLIN RESOURCES INC
BEN
8,333,476
5.500%
8,333,476increase
(New Position)
Filing
History
2022-02-03
2:02 pm
Purchase
2021-12-3113GEyePoint Pharmaceuticals, Inc.
EYPT
FRANKLIN RESOURCES INC
BEN
4,947,165
14.600%
3,533,218increase
(+249.88%)
Filing
History
2021-08-13
4:31 pm
Purchase
2021-08-0313GEyePoint Pharmaceuticals, Inc.
EYPT
RA Capital Management, L.P.1,606,859
5.600%
1,606,859increase
(New Position)
Filing
History
2021-07-26
5:21 pm
Purchase
2021-07-1413GEyePoint Pharmaceuticals, Inc.
EYPT
SUVRETTA CAPITAL MANAGEMENT LLC1,595,164
5.600%
1,595,164increase
(New Position)
Filing
History
2021-02-12
4:06 pm
Purchase
2021-02-0413GEyePoint Pharmaceuticals, Inc.
EYPT
ADAGE CAPITAL PARTNERS GP L.L.C.1,500,000
5.230%
1,500,000increase
(New Position)
Filing
History
2021-02-01
2:18 pm
Purchase
2020-12-3113GEyePoint Pharmaceuticals, Inc.
EYPT
FRANKLIN RESOURCES INC
BEN
1,413,947
7.800%
1,413,947increase
(New Position)
Filing
History
2021-01-21
6:21 pm
Purchase
2020-12-3113DEyePoint Pharmaceuticals, Inc.
EYPT
Ocumension Therapeutics3,010,722
16.600%
3,010,722increase
(New Position)
Filing
History
2020-11-10
10:47 am
Purchase
2020-10-3113GEyePoint Pharmaceuticals, Inc.
EYPT
FRANKLIN RESOURCES INC
BEN
1,413,750
10.600%
1,413,750increase
(New Position)
Filing
History
Goto Prev, 0, 1